Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia

Miyuki Morozumi, Keiko Hasegawa, Naoko Chiba, Satoshi Iwata, Naohisa Kawamura, Haruo Kuroki, Takeshi Tajima, Kimiko Ubukata

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Between April 2002 and March 2003, to detect Mycoplasma pneumoniae by polymerase chain reaction (PCR), a primer set designed for the 16S rRNA gene was used to examine clinical samples from 369 children with community-acquired pneumonia. Samples were collected from 12 Japanese institutions participating in a study group concerning acute respiratory infectious diseases. The sensitivity of primers - 2 CFU per reaction tube, using M. pneumoniae M129, a standard strain - was calculated to represent 1.1 × 103 M. pneumoniae organisms adherent to the tip of the swab used to collect clinical samples. Results for PCR were obtained within 2.6 h. Cases identified by PCR, cultures, and serologic tests were 68 (18.4%), 53 (14.4%), and 76 (20.6%) respectively. Among 57 PCR-positive patients tested serologically, 56 showed a significant elevation or rise in antibody titer. PCR positivity was high among patients prescribed β-lactam antibiotics (86.7%) or no antibiotic (87.0%) before PCR analysis, but was low among patients receiving macrolides, new quinolones, or tetracyclines (37.5%). We concluded that the PCR constructed by us had a high probability for confirming a diagnosis of M. pneumoniae pneumonia and for guiding antibiotic choice for patients not yet treated.

Original languageEnglish
Pages (from-to)274-279
Number of pages6
JournalJournal of Infection and Chemotherapy
Volume10
Issue number5
DOIs
Publication statusPublished - 2004 Oct
Externally publishedYes

Fingerprint

Mycoplasma pneumoniae
Pneumonia
Polymerase Chain Reaction
Anti-Bacterial Agents
Mycoplasma Pneumonia
Lactams
Tetracyclines
Quinolones
Macrolides
Serologic Tests
rRNA Genes
Communicable Diseases
Antibodies

Keywords

  • Community-acquired pneumonia
  • Mycoplasma pneumoniae
  • PCR identification

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Morozumi, M., Hasegawa, K., Chiba, N., Iwata, S., Kawamura, N., Kuroki, H., ... Ubukata, K. (2004). Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia. Journal of Infection and Chemotherapy, 10(5), 274-279. https://doi.org/10.1007/s10156-004-0338-y

Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia. / Morozumi, Miyuki; Hasegawa, Keiko; Chiba, Naoko; Iwata, Satoshi; Kawamura, Naohisa; Kuroki, Haruo; Tajima, Takeshi; Ubukata, Kimiko.

In: Journal of Infection and Chemotherapy, Vol. 10, No. 5, 10.2004, p. 274-279.

Research output: Contribution to journalArticle

Morozumi, M, Hasegawa, K, Chiba, N, Iwata, S, Kawamura, N, Kuroki, H, Tajima, T & Ubukata, K 2004, 'Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia', Journal of Infection and Chemotherapy, vol. 10, no. 5, pp. 274-279. https://doi.org/10.1007/s10156-004-0338-y
Morozumi, Miyuki ; Hasegawa, Keiko ; Chiba, Naoko ; Iwata, Satoshi ; Kawamura, Naohisa ; Kuroki, Haruo ; Tajima, Takeshi ; Ubukata, Kimiko. / Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia. In: Journal of Infection and Chemotherapy. 2004 ; Vol. 10, No. 5. pp. 274-279.
@article{811c9779642d4bfcac36197f605f155e,
title = "Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia",
abstract = "Between April 2002 and March 2003, to detect Mycoplasma pneumoniae by polymerase chain reaction (PCR), a primer set designed for the 16S rRNA gene was used to examine clinical samples from 369 children with community-acquired pneumonia. Samples were collected from 12 Japanese institutions participating in a study group concerning acute respiratory infectious diseases. The sensitivity of primers - 2 CFU per reaction tube, using M. pneumoniae M129, a standard strain - was calculated to represent 1.1 × 103 M. pneumoniae organisms adherent to the tip of the swab used to collect clinical samples. Results for PCR were obtained within 2.6 h. Cases identified by PCR, cultures, and serologic tests were 68 (18.4{\%}), 53 (14.4{\%}), and 76 (20.6{\%}) respectively. Among 57 PCR-positive patients tested serologically, 56 showed a significant elevation or rise in antibody titer. PCR positivity was high among patients prescribed β-lactam antibiotics (86.7{\%}) or no antibiotic (87.0{\%}) before PCR analysis, but was low among patients receiving macrolides, new quinolones, or tetracyclines (37.5{\%}). We concluded that the PCR constructed by us had a high probability for confirming a diagnosis of M. pneumoniae pneumonia and for guiding antibiotic choice for patients not yet treated.",
keywords = "Community-acquired pneumonia, Mycoplasma pneumoniae, PCR identification",
author = "Miyuki Morozumi and Keiko Hasegawa and Naoko Chiba and Satoshi Iwata and Naohisa Kawamura and Haruo Kuroki and Takeshi Tajima and Kimiko Ubukata",
year = "2004",
month = "10",
doi = "10.1007/s10156-004-0338-y",
language = "English",
volume = "10",
pages = "274--279",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia

AU - Morozumi, Miyuki

AU - Hasegawa, Keiko

AU - Chiba, Naoko

AU - Iwata, Satoshi

AU - Kawamura, Naohisa

AU - Kuroki, Haruo

AU - Tajima, Takeshi

AU - Ubukata, Kimiko

PY - 2004/10

Y1 - 2004/10

N2 - Between April 2002 and March 2003, to detect Mycoplasma pneumoniae by polymerase chain reaction (PCR), a primer set designed for the 16S rRNA gene was used to examine clinical samples from 369 children with community-acquired pneumonia. Samples were collected from 12 Japanese institutions participating in a study group concerning acute respiratory infectious diseases. The sensitivity of primers - 2 CFU per reaction tube, using M. pneumoniae M129, a standard strain - was calculated to represent 1.1 × 103 M. pneumoniae organisms adherent to the tip of the swab used to collect clinical samples. Results for PCR were obtained within 2.6 h. Cases identified by PCR, cultures, and serologic tests were 68 (18.4%), 53 (14.4%), and 76 (20.6%) respectively. Among 57 PCR-positive patients tested serologically, 56 showed a significant elevation or rise in antibody titer. PCR positivity was high among patients prescribed β-lactam antibiotics (86.7%) or no antibiotic (87.0%) before PCR analysis, but was low among patients receiving macrolides, new quinolones, or tetracyclines (37.5%). We concluded that the PCR constructed by us had a high probability for confirming a diagnosis of M. pneumoniae pneumonia and for guiding antibiotic choice for patients not yet treated.

AB - Between April 2002 and March 2003, to detect Mycoplasma pneumoniae by polymerase chain reaction (PCR), a primer set designed for the 16S rRNA gene was used to examine clinical samples from 369 children with community-acquired pneumonia. Samples were collected from 12 Japanese institutions participating in a study group concerning acute respiratory infectious diseases. The sensitivity of primers - 2 CFU per reaction tube, using M. pneumoniae M129, a standard strain - was calculated to represent 1.1 × 103 M. pneumoniae organisms adherent to the tip of the swab used to collect clinical samples. Results for PCR were obtained within 2.6 h. Cases identified by PCR, cultures, and serologic tests were 68 (18.4%), 53 (14.4%), and 76 (20.6%) respectively. Among 57 PCR-positive patients tested serologically, 56 showed a significant elevation or rise in antibody titer. PCR positivity was high among patients prescribed β-lactam antibiotics (86.7%) or no antibiotic (87.0%) before PCR analysis, but was low among patients receiving macrolides, new quinolones, or tetracyclines (37.5%). We concluded that the PCR constructed by us had a high probability for confirming a diagnosis of M. pneumoniae pneumonia and for guiding antibiotic choice for patients not yet treated.

KW - Community-acquired pneumonia

KW - Mycoplasma pneumoniae

KW - PCR identification

UR - http://www.scopus.com/inward/record.url?scp=11244273184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11244273184&partnerID=8YFLogxK

U2 - 10.1007/s10156-004-0338-y

DO - 10.1007/s10156-004-0338-y

M3 - Article

C2 - 16163461

AN - SCOPUS:11244273184

VL - 10

SP - 274

EP - 279

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 5

ER -